SYMBICORT
Code : SYM01
Price:
Contact
Manufacturer
Present/Packing Symbicort turbuhaler 160/4.5 mcg
Symbicort 60 dose x 1's
Symbicort 120 dose x 1's
Price
Features
Delivery
Share this product to others
Shopping
guide
Add to cart
Share this product to friends and family
SYMBICORT
Manufacturer:
AstraZeneca
Contents:
Per 80/4.5 mcg dose Budesonide 80 mcg, formoterol fumarate dihydrate 4.5 mcg. Per 160/4.5 mcg dose Budesonide 160 mcg, formoterol fumarate dihydrate 4.5 mcg. Per 320/9 mcg dose Budesonide 320 mcg, formoterol fumarate dihydrate 9 mcg
Indications:
Regular
treatment of asthma using combination of inhaled corticosteroid &
long-acting β2-agonist in patients not adequately controlled w/ inhaled
corticosteroids & as needed inhaled short-acting β2-agonists or patients
already adequately controlled on both inhaled corticosteroids & long-acting
β2-agonists. Turbuhaler 160/4.5 mcg & 320/9 mcg Symptomatic treatment of
patients w/ severe COPD (FEV1 <50% predicted normal) & history of
repeated exacerbations who have significant symptoms despite regular therapy w/
long-acting bronchodilators.
Contraindications:
Hypersensitivity to lactose.
Special Precautions:
Turbuhaler 80/4.5 mcg/inhalation is not
appropriate in patients w/ severe asthma. Not intended for the initial
management of asthma. Prophylactic use eg before exercise. Dose should
be tapered when the treatment is discontinued & should not be
stopped abruptly. Exacerbation episodes, worsening or acutely
deteriorating asthma; adrenal impairment due to previous systemic
steroid therapy or high dose emergency corticosteroid therapy; prolonged
treatment w/ high dose inhaled corticosteroids; thyrotoxicosis,
phaeochromocytoma, DM, untreated hypokalaemia, hypertrophic obstructive
cardiomyopathy, idiopathic subvalvular aortic stenosis, severe HTN,
aneurysm or other severe CV disorders eg ischaemic heart disease,
tachyarrhythmias or severe heart failure; prolonged QTc-interval; active
or quiescent pulmonary TB; fungal & viral infections in the
airways; unstable asthma w/ variable use of rescue bronchodilators,
acute severe asthma; hepatic or renal impairment, severe liver
cirrhosis. Pregnancy & lactation. Childn <12 yr & patients
taking potent CYP3A4 inhibitors (maintenance & reliever therapy).
Childn <6 yr.
Dosage:
Turbuhaler 160/4.5 mcg &
80/4.5 mcg Asthma (maintenance & reliever therapy) Adult & adolescent
≥12 yr Maintenance dose: 2 inhalations/day, 1 inhalation in the morning &
evening or as 2 inhalations either in the morning or evening. Additional
inhalations may be taken as needed but not >6 inhalations/occasion. A total
daily dose of up to 12 inhalations could be used for a limited period.
Maintenance treatment w/ a separate rapid-acting bronchodilator as rescue Adult
≥18 yr 1-2 inhalations bd. Max: 4 inhalations bd. Adolescent 12-17 yr 1-2
inhalations bd. Turbuhaler 80/4.5 mcg Childn ≥6 yr 2 inhalations bd. Turbuhaler
320/9 mcgAsthma Adult ≥18 yr 1 inhalation bd. Max: 2 inhalations bd. Adolescent
12-17 yr 1 inhalation bd. COPD Adult Turbuhaler 320/9 mcg 1 inhalation bd.
Turbuhaler 160/4.5 mcg 2 inhalations bd.
Class:
Antiasthmatic & COPD
Preparations
Presentation/Packing:
Symbicort turbuhaler 160/4.5 mcg
Symbicort 60 dose x 1's
Symbicort 120 dose x 1's
Details:
MyPhuocPharmacy – (08) 62581003
Per 80/4.5 mcg dose Budesonide 80 mcg, formoterol fumarate dihydrate 4.5 mcg. Per 160/4.5 mcg dose Budesonide 160 mcg, formoterol fumarate dihydrate 4.5 mcg. Per 320/9 mcg dose Budesonide 320 mcg, formoterol fumarate dihydrate 9 mcg
Turbuhaler 160/4.5 mcg &
80/4.5 mcg Asthma (maintenance & reliever therapy) Adult & adolescent
≥12 yr Maintenance dose: 2 inhalations/day, 1 inhalation in the morning &
evening or as 2 inhalations either in the morning or evening. Additional
inhalations may be taken as needed but not >6 inhalations/occasion. A total
daily dose of up to 12 inhalations could be used for a limited period.
Maintenance treatment w/ a separate rapid-acting bronchodilator as rescue Adult
≥18 yr 1-2 inhalations bd. Max: 4 inhalations bd. Adolescent 12-17 yr 1-2
inhalations bd. Turbuhaler 80/4.5 mcg Childn ≥6 yr 2 inhalations bd. Turbuhaler
320/9 mcgAsthma Adult ≥18 yr 1 inhalation bd. Max: 2 inhalations bd. Adolescent
12-17 yr 1 inhalation bd. COPD Adult Turbuhaler 320/9 mcg 1 inhalation bd.
Turbuhaler 160/4.5 mcg 2 inhalations bd.
Updating
Turbuhaler 80/4.5 mcg/inhalation is not
appropriate in patients w/ severe asthma. Not intended for the initial
management of asthma. Prophylactic use eg before exercise. Dose should
be tapered when the treatment is discontinued & should not be
stopped abruptly. Exacerbation episodes, worsening or acutely
deteriorating asthma; adrenal impairment due to previous systemic
steroid therapy or high dose emergency corticosteroid therapy; prolonged
treatment w/ high dose inhaled corticosteroids; thyrotoxicosis,
phaeochromocytoma, DM, untreated hypokalaemia, hypertrophic obstructive
cardiomyopathy, idiopathic subvalvular aortic stenosis, severe HTN,
aneurysm or other severe CV disorders eg ischaemic heart disease,
tachyarrhythmias or severe heart failure; prolonged QTc-interval; active
or quiescent pulmonary TB; fungal & viral infections in the
airways; unstable asthma w/ variable use of rescue bronchodilators,
acute severe asthma; hepatic or renal impairment, severe liver
cirrhosis. Pregnancy & lactation. Childn <12 yr & patients
taking potent CYP3A4 inhibitors (maintenance & reliever therapy).
Childn <6 yr.